Yasin Akbari is an associate in the firm's Business Law Department and a member of its Technology and Life Sciences group. Ms. Akbari’s practice is focused on mergers and acquisitions, strategic investments and royalty-based financings, securities offerings, and other complex transactions. She also counsels companies on ongoing corporate matters, including governance and SEC compliance.

Ms. Akbari is a member of the Boston Bar Association and the Women’s Bar Association. She joined Goodwin in 2015.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Ms. Akbari’s recent client representations include, among others:

  • Spark Therapeutics in its pending $4.8 billion sale to Roche
  • Twilio in its $3 billion acquisition of SendGrid
  • Keryx Biopharmaceuticals in its $1 billion merger with Akebia Therapeutics
  • Cornerstone OnDemand in its $300 million strategic investment led by Silver Lake
  • Royalty Pharma in multiple transactions, including (i) its $827 million acquisition of Ligand Pharmaceuticals’ royalties on sales of Promacta, (ii) its purchase of worldwide royalties on sales of tazemetostat from Eisai and Epizyme and concurrent $100 million equity investment in Epizyme, and (iii) its $100 million purchase of a synthetic royalty from, and equity investments of up $250 million in, Biohaven
  • Cabaletta Bio in its $75 million initial public offering
  • TCR2 Therapeutics in its $75 million initial public offering
  • bluebird bio in its December 2016, December 2017, June 2017 and July 2018 follow-on public offerings, raising over $2 billion
  • Blueprint Medicines in its December 2016, December 2017 and April 2019 follow-on public offerings, raising $815 million

Recognition

While attending law school, Ms. Akbari served as a note editor for the International and Comparative Law Review and chaired the Women's Law center.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2015
Boston College Law School
(cum laude)
M.A., 2011
Yale University
B.A., 2010
Johns Hopkins University

Admissions

Bar

Massachusetts
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师